How to Spot the Signs of Three Major Mental Health Issues in the Workplace

first_imgHow to Spot the Signs of Three Major Mental Health Issues in the WorkplaceBy kooth on 25 Nov 2020 in PROMOTED CONTENT, Anxiety, Stress, Mental health conditions, Latest News, Mental health, Personnel Today No comments yet. Leave a Reply Click here to cancel reply.Comment Name (required) Email (will not be published) (required) Website Together alone: staying well as OH practitioners in challenging timesDr Nerina Ramlakhan explains how occupational health professionals can balance supporting the health needs of employers and employees while, at… Creating a different kind of workplaceMental Health Awareness Week encourages employers to focus on ‘kindness’ at a time when workers throughout the world are beset by feelings of uncertainty. COVID-19 has had a major impact on the UK’s mental health, something that will have devastating repercussions for years to come. Kooth Plc, the UK’s leading digital mental health services, has seen an increase in demand for services as people struggle to cope with anxiety, stress and job insecurity. Our data from the start of the pandemic period (March 2020-June 2020) revealed noticeable increases in several key presenting issues – family relationships, self worth and suicidal thoughts. As a result of the stigma still surrounding mental illness, some employees may feel reluctant to share their struggles and mental health problems can often go unrecognised. It’s not always easy to spot the signs of mental health illness so here are some signs to watch out for:Family Relationship BreakdownsWhy is this rising? With many couples and families now spending much of the day in close quarters juggling school runs, Zoom meetings, and meal planning, tensions can run high. This combined with mounting debt, not being able to socialise or even go to the gym to let off steam, means employees could be feeling angry, upset or frustrated – although it may not always be obvious when people have different outlooks and coping mechanisms when they feel overwhelmed.How do you spot it? If you notice that someone you work with is talking about friction with their families – perhaps an argument they have had or a change in enthusiasm towards the people they live with – they may want somebody to confide in. You may also notice that your colleague is prone to sudden outbursts or is often short tempered. Online counsellors and peer support forums are a fantastic source of support, no matter how small the issue may seem. If an employee is opening up to you and you feel you’re not able to help as much as you’d like, having somewhere to signpost them to is important.Self WorthWhy is this rising? Self worth involves a self appraisal of things such as appearance, beliefs, feelings, behaviours and performance. Whilst genetics undoubtedly play a part, our interactions with others and the world around are usually central to these appraisals. Since the COVID-19 pandemic, opportunities for such interactions have been at best limited and at worst negative. From relationship breakdowns to loss of a regular exercise regime or engagement in activities that promote feelings of happiness and positivity, there are many factors at play, influencing how we feel about ourselves.How do you spot it? There are a few ways to spot a colleague displaying self worth issues. Firstly, they may seem uninterested in setting goals for the future as they are lacking confidence. You may also notice them becoming defensive or becoming withdrawn. Lastly, people with self esteem issues often talk down to themselves and/or appear self-defeating.Suicidal ThoughtsWhy is this rising? The emotional, financial and social impact of COVID-19 is unprecedented for the vast majority. Job losses aside, the costs of weekly grocery shops have increased significantly; sense of belonging and self worth have been hugely compromised and anxiety regarding what lies ahead is almost commonplace. How do you spot it? Spotting someone with suicidal thoughts is tricky as the symptoms can differ between people and their situations. There are some specific behavioural and physical changes that you might notice in others including being distracted, anger, low mood, weight loss/weight gain and disinterest in personal appearance or hygiene. Early intervention is imperative to helping to prevent presenting issues such as low mood or anxiety from escalating into suicidal thoughts or even self harm. If you think someone is in crisis, then you should try and persuade them to contact a crisis service such as Samaritans by calling 116 123.Why digital mental wellbeing toolkits are the way to goAnalysis by Annie Meharg, CCO of KoothIt is clear that Covid-19 has had a negative impact on our mental health. Since the start of the pandemic, Kooth has seen unprecedented demand for its services. Providing your employees with a safe and anonymous space to access mental health and emotional wellbeing support is crucial. Kooth users can receive synchronous or asynchronous support from qualified human practitioners via booked or drop-in sessions. We also provide clinically proven and research-backed tools such as pre moderated and safeguarded peer-to-peer community forums, thousands of advice articles through the Kooth magazine, goal setting and journaling supported by activities.Traditionally, Employee Assistance Programmes (EAPs) have focussed on reactive solutions such as phone counselling and GP appointments. At Kooth, we take a forward thinking, proactive approach more in tune with the times we are living in. Kooth’s digital mental health toolkit is not only designed to help people when they need it most but to also support people when they just need a bit of advice. Kooth keeps anonymity at the forefront of its platform, whilst still giving you the reporting tools you need to assess your company’s mental health as a whole. Kooth uses 19 years of experience and data to constantly improve our product and clinical offerings. Our platform has one of the largest mental health data sets and is the only online mental health platform that captures real time insights on what is really affecting your workplace. Additionally, we’re the second biggest provider of mental health data to Public Health England and our data has been featured on Panorama and BBC News.If you’re interested in learning more about how digital mental health toolkits can benefit your organisation, I’d love to have a chat with you. Connect with me on linkedin or email [email protected] Related posts: Previous Article Next Articlelast_img read more

SARS vaccine linked to liver damage in ferret study

first_imgDec 6, 2004 (CIDRAP News) – Researchers in Canada who found hepatitis in ferrets after injecting the animals with an experimental vaccine for SARS (severe acute respiratory syndrome) are urging caution as other investigators develop and test SARS vaccines.As reported in the November issue of the Journal of Virology, the study involved a vaccine developed by senior author Jingxin Cao, PhD, of the Public Health Agency of Canada’s National Microbiological Laboratory in Winnipeg, Man. Cao had created a vaccine from recombinant modified vaccinia virus Ankara (rMVA) and the distinctive spike protein that marks the SARS coronavirus (SARS-CoV). The trial vaccine is called rMVA-S.The team chose ferrets for the study on the basis of their reported susceptibility to SARS infection, Cao told CIDRAP News.At the Canadian Science Centre for Human and Animal Health’s Biosafety Level 4 lab in Winnipeg, three ferrets were injected with the rMVA-S vaccine, three with parental MVA, and three with saline solution. They received booster immunizations 2 weeks later.Then the ferrets were exposed intranasally to the SARS virus, which infected more than 8,000 people and killed 774 between November 2002 and July 2003.On the plus side, immunization with rMVA-S induced a rapid immune response following exposure to the virus, the researchers wrote. The ferrets displayed no clinical signs of illness, but viral RNA was found in pharyngeal swabs and blood samples taken from all the ferrets.But researchers unexpectedly discovered a downside when they checked the ferrets’ liver health. Ferrets vaccinated with rMVA-S and exposed to SARS-CoV had elevated levels of an enzyme that indicates liver damage. Examination of liver sections showed that the ferrets had severe hepatitis. Only mild hepatitis was found in the ferrets injected with parental MVA or saline.It’s uncommon to perform the tests that revealed the hepatitis, said Kelly Keith, acting communications manager for the Canadian Science Centre for Human and Animal Health. This study will help ensure that any other SARS vaccine will be safer, as scientists should know to check for this possible side effect.”Extra caution should be taken in proposed human trials of SARS vaccines due to the potential liver damage from immunization and virus infection,” the research report states.Cao said he hopes that others recognize the significance of the hepatitis among the vaccinated ferrets. “For future human vaccine development, we must pay attention to that effect,” he said.The lead author of the study, Hana Weingartl, PhD, head of special pathogens for Canada’s National Microbiology Laboratory in Winnipeg, said she and her fellow researchers are seeking a grant to continue their work. “We would like to look more closely at why we saw the liver damage in those animals,” she said. “It would be good to know what not to do.”The findings underscore how little is understood about SARS, which emerged in southern China in November 2002. Since its discovery, scientists have raced to contain it and develop a vaccine. Weingartl and Cao’s study is one of several vaccine investigations in various stages in several countries.Researchers need a better understanding of how the virus damages the host, Weingartl said.In an unrelated SARS vaccine investigation, the Chinese government yesterday announced that a vaccine proved safe and effective in a phase 1 clinical trial. Thirty-six volunteers who had been vaccinated reported no unusual physical reactions after 56 days, Agence France-Presse reported (AFP). In addition, antibodies were found in 24 of those vaccinated, the story said.Testing began in May with 18 men and 18 women from 21 to 40 years old following what the government termed successful animal tests, AFP reported. The vaccine won’t be ready for commercial use until two more testing phases are completed.Weingartl H, Czub M, Czub S, et al. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virology 2004;78(22):12672-6 [Abstract]last_img read more